CRISPR-based Diagnostic Platforms
CRISPR-based diagnostics can offer quick and accurate nucleic acid testing for infectious and noninfectious diseases
Published:Mar 09, 2021
|Updated:Mar 18, 2021
|1 min read
Though CRISPR-Cas systems are largely known for their gene editing abilities, researchers have shown that they can be harnessed for molecular diagnostic applications. CRISPR-based molecular diagnostics offer quick and accurate nucleic acid testing with single base-pair specificity, without the need of a complex laboratory setup.
Here, we explore recent diagnostic platforms based on different CRISPR-associated proteins.
To learn about the different CRISPR-based diagnostics platforms, download the FREE infographic courtesy of Clinical Lab Manager.